VANGUARD GROUP INC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 10:49 am Sale | 2026-03-13 | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 0 0.000% | -7,882,515 (Position Closed) | Filing |
| 2025-10-31 11:05 am Sale | 2025-09-30 | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 7,882,515 8.470% | -1,374,978 (-14.85%) | Filing |
| 2025-07-29 1:54 pm Sale | 2025-06-30 | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,257,493 10.040% | -696,740 (-7.00%) | Filing |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,954,233 11.120% | 642,472 (+6.90%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,311,761 11.490% | 162,240 (+1.77%) | Filing |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,149,521 11.460% | 852,657 (+10.28%) | Filing |